{
    "code": 0,
    "data": [
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release (Revised)",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)",
            "news_body": "Strides Pharma Inc receives USFDA closure report (EIR) for its formulations facility at Chestnut Ridge New York\r\n\r\nInspection included Drug Device Combinations covering our recent filing in Nasal Sprays domain",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=258bbc32-e404-4002-894b-82ba273a4c59.pdf",
            "news_date": "2026-02-05 08:54:34"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Strides Pharma Inc receives USFDA closure report (EIR) for its formulations facility at Chestnut Ridge New York\r\n\r\nInspection included Drug Device Combinations covering our recent filing in Nasa Sprays domain",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9e8191a-4aa7-470b-88b3-ab4f0f7db8cc.pdf",
            "news_date": "2026-02-05 08:45:56"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst/ Institutional Investors Meet - Intimation under Regulation 30 of SEBI Listing Regulations",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ced99df-34a6-40a9-83b5-2b56b7e6bbfc.pdf",
            "news_date": "2026-02-04 21:15:37"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31 2025.",
            "news_id": "5bcb52c9-5492-4fe6-aaf3-108da48b149f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc699e4f-05b6-40ff-90e4-86189ee75d00.pdf",
            "news_date": "2026-02-03 16:52:57",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earnings call pertaining to unaudited financial results of the Company for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc699e4f-05b6-40ff-90e4-86189ee75d00.pdf",
            "news_date": "2026-02-03 16:52:57"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Response To Query Dated Feb 1 2026 - Clarification On Volume Movement In The Equity Shares Of The Company",
            "news_body": "Response to BSE Query dated Feb 1 2026 reference no. L/SURV/ONL/PV/APJ/2025-26/889",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=029908fe-0a01-4352-bffb-c5ed5fed54c1.pdf",
            "news_date": "2026-02-02 11:54:36"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Strides Pharma Science Ltd",
            "news_body": "The Exchange has sought clarification from Strides Pharma Science Ltd on February 01 2026 with reference to Movement in Volume. <BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2026-02-01 12:42:12"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement - Unaudited Financial Results for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32aa9a60-9799-476b-b8fb-bb31b04a0d44.pdf",
            "news_date": "2026-01-31 15:49:08"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter and nine months ended December 31 2025",
            "news_id": "6976c8c4-c508-468f-b6f0-8b9525cff60b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e6853af-1a57-4bb8-964f-8b9fb7bc8010.pdf",
            "news_date": "2026-01-30 20:38:31",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e6853af-1a57-4bb8-964f-8b9fb7bc8010.pdf",
            "news_date": "2026-01-30 20:38:31"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting - Financial Results Q3 FY 26",
            "news_body": "Outcome of Board meeting - Financial Results Q3 FY 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8ba27c4-9178-4508-a73c-adb29298b063.pdf",
            "news_date": "2026-01-30 13:00:32"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Strides Press release on Q3 FY 26 financials",
            "news_id": "a7950f78-15b6-44cf-86a1-0762c22f19ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ada5c53-065b-4cf6-a49a-8e35f2171226.pdf",
            "news_date": "2026-01-30 12:56:23",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Strides Press release on Q3 FY 26 financials",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ada5c53-065b-4cf6-a49a-8e35f2171226.pdf",
            "news_date": "2026-01-30 12:56:23"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Strides continues to deliver exceptional performance with highest ever quarterly EBITDA of Rs.2359 million in Q3 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c03a8e53-e810-44e7-b3f0-367dd1e217b6.pdf",
            "news_date": "2026-01-30 12:54:27"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": " Un-Audited Financial Results (Consolidated & Standalone) \r\nFor The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Unaudited financial results for quarter and nine months ended December 31 2025",
            "news_id": "af508842-2a54-442c-9509-99742aeda575",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b2f87ed-dcea-451f-ab08-edef5b9f5709.pdf",
            "news_date": "2026-01-30 12:49:42",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": " Un-Audited Financial Results (Consolidated & Standalone) \r\nFor The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Unaudited financial results for quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b2f87ed-dcea-451f-ab08-edef5b9f5709.pdf",
            "news_date": "2026-01-30 12:49:42"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Earnings Call to discuss the Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb965179-9310-4e23-9947-505666907fcf.pdf",
            "news_date": "2026-01-23 21:38:45"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 inter alia to consider and approve Intimation regarding Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=183dbbdd-7b33-4717-b9ea-92b8c9bcd0b4.pdf",
            "news_date": "2026-01-23 19:12:00"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 received from RTA of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d09786e-f011-4d09-9795-b8cf6e80c28b.pdf",
            "news_date": "2026-01-14 15:07:46"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Completion Of US-FDA Inspection At The Formulations Facility Of Strides Pharma Inc. USA A Step-Down Wholly Owned Subsidiary Of The Company",
            "news_body": "Completion of US-FDA Inspection at Formulations Facility of Strides Pharma Inc.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0459398-b555-41e9-97e3-965bfc618f19.pdf",
            "news_date": "2025-12-24 18:34:35"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding closure of trading window for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c3453f1-3ebe-4d88-a95d-aebf1c3e1295.pdf",
            "news_date": "2025-12-22 17:55:13"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Intimation under reg 30 - Resignation of Group CHRO",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46e002b0-ea1d-4a25-bc87-c7a8a9a9f408.pdf",
            "news_date": "2025-12-03 11:47:48"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst/ Institutional Investors Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43e0fefb-094f-4376-abbc-40668222e9e1.pdf",
            "news_date": "2025-11-17 18:01:10"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Transcript of Earnings Call pertaining to unaudited Financial Results of the Company for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb389025-5ce3-44c1-8940-cfd76882df76.pdf",
            "news_date": "2025-11-05 15:35:58"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advertisement - Unaudited financial results of the Company for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b516fd2-3a9e-4d81-9baa-1a91fce3629d.pdf",
            "news_date": "2025-11-01 16:15:30"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter and half year ended September 30 2025",
            "news_id": "07cfb255-5e11-4183-9ea0-09540fdbe1f7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebb37d52-a27e-4beb-8f15-1f1b2f5e966e.pdf",
            "news_date": "2025-10-31 20:56:17",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebb37d52-a27e-4beb-8f15-1f1b2f5e966e.pdf",
            "news_date": "2025-10-31 20:56:17"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Outcome of Board Meeting held on October 31 2025 - Press Release and Earnings Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5e15d98-b7ee-4831-a7ba-e622041afc97.pdf",
            "news_date": "2025-10-31 13:07:23"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Consolidated & Standalone) For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Consolidated & Standalone) for the quarter and half year ended September 30 2025",
            "news_id": "69ad4d6a-bf21-4a29-a5c0-9447334a8fd3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab75eac0-a270-452f-8dbe-111914b96f17.pdf",
            "news_date": "2025-10-31 13:05:22",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Consolidated & Standalone) For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Consolidated & Standalone) for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab75eac0-a270-452f-8dbe-111914b96f17.pdf",
            "news_date": "2025-10-31 13:05:22"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Earnings Call to discuss unaudited financial results of the Company for the quarter and half-year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8346c37-c724-4185-bf31-72e9cd40b8c4.pdf",
            "news_date": "2025-10-24 21:46:42"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 inter alia to consider and approve Intimation regarding Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8764488e-3d40-4bec-adaf-e6633a6a75e3.pdf",
            "news_date": "2025-10-24 18:55:40"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Strides And Incepta Partner To Expand WomenS Health Access With WHO-Prequalified Contraceptive",
            "news_body": "Strides and Incepta Partner to Expand Womens Health Access with WHO-Prequalified Contraceptive",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6ba39e9-7eea-44f6-baf1-6bd1c5b89439.pdf",
            "news_date": "2025-10-17 15:18:59"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation regarding Closure of Trading Window for Q2 and Half Year - FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d601a9ca-af60-42f9-8163-1908db2f12cd.pdf",
            "news_date": "2025-09-25 14:57:04"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Strides Sustainability Report For FY25",
            "news_body": "Strides Sustainability Report for FY25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b341cd5c-0fe6-4b59-8d45-a1b37e65171f.pdf",
            "news_date": "2025-09-24 11:01:07"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "2Nd Reminder To Shareholders Whose Shares Are Due To Be Transferred To IEPF",
            "news_body": "2nd Reminder to Shareholders whose shares are due to be transferred to IEPF",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1dd1d36-1ffc-467d-8108-df92f34d49a4.pdf",
            "news_date": "2025-09-19 18:02:18"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Schedule of Analyst/ Institutional Investors Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73182243-5108-452d-aaa7-a8d69263bb6d.pdf",
            "news_date": "2025-09-17 18:39:37"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Strides Enters into a Strategic Product Development Partnership with Kenox to Expand Nasal Spray Portfolio for the US Market",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da6421b1-207c-419f-a9fe-d465bc624581.pdf",
            "news_date": "2025-09-08 18:22:00"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Schedule of Analyst/ Institutional Investors Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dbd5ca05-0d09-4ef4-8899-2afa0e577118.pdf",
            "news_date": "2025-08-26 17:36:49"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Deregistration Of A Non-Operating Step-Down Subsidiary Of The Company In South Africa",
            "news_body": "Deregistration of a non-operating step-down subsidiary of the Company in South Africa.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac26f849-86ad-428a-88cf-fa63fc701975.pdf",
            "news_date": "2025-08-25 17:28:58"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Intimation regarding Voting Results and Scrutinizer Report of 34th Annual General Meeting of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ccdcd40-bf27-4d4c-8c5f-ae4fa97f1a66.pdf",
            "news_date": "2025-08-08 21:09:26"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "We would like to inform you that Management of Strides will be attending investor conference organised by Emkay Global Financial Services Limited on August 12 2025 at 10:00 hrs in Mumbai.\r\n\r\nEarnings deck of Q1 FY26 (which was intimated/ uploaded on Stock Exchange/ Company website on July 29 2025) shall be the discussion document during these meetings. The same is enclosed for ready reference.\r\n\r\nThis is for your information and records.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=981eabbc-a437-4962-97d9-012307c88db8.pdf",
            "news_date": "2025-08-07 20:25:32"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Proceedings of 34th Annual General Meeting of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff2353e5-8eff-454d-b5b8-bf335302ccbf.pdf",
            "news_date": "2025-08-07 16:32:55"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Transcript of Earnings Call pertaining to unaudited financial results of the Company for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18a7ad25-fba0-4c37-a54f-e50372724d01.pdf",
            "news_date": "2025-08-04 19:08:26"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement- Unaudited Financial Results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a3e9c00-c82d-4d60-93e7-d0da769e3529.pdf",
            "news_date": "2025-07-30 18:01:49"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter ended June 30 2025.",
            "news_id": "3d106277-bf46-4eb0-ba90-642871ba774e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f34981f1-c07a-4bcf-b5e6-231a4daae171.pdf",
            "news_date": "2025-07-29 20:57:25",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Call pertaining to the Unaudited Financial Results for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f34981f1-c07a-4bcf-b5e6-231a4daae171.pdf",
            "news_date": "2025-07-29 20:57:25"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Allotment Of Shares Under ESOP Scheme",
            "news_body": "Allotment of shares under the ESOP Scheme",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2fc98a7d-05c0-401a-a6d0-4acf9f7699a0.pdf",
            "news_date": "2025-07-29 12:48:58"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Amendment To Code Of Fair Disclosure Of UPSI",
            "news_body": "Amendment to code of fair disclosure of UPSI",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a74fbff-d467-470e-a1d0-46fcccdf9f32.pdf",
            "news_date": "2025-07-29 12:44:39"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Strides Delivers a strong Q1 FY 2026 with Rs.11197 million Revenue Rs. 2181 million EBITDA and Rs. 1140 million Operational PAT.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97a20ca8-f543-4456-91e9-a60daa8508c0.pdf",
            "news_date": "2025-07-29 12:41:45"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of Equity shares under the ESOP Scheme",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f60fb57a-d6e4-4330-b92e-70b16b2ae4c9.pdf",
            "news_date": "2025-07-29 12:37:10"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results (Consolidated & Standalone) For The Quarter Ended June 30 2025",
            "news_body": "Financial Results (Consolidated & Standalone) for the quarter ended June 30 2025",
            "news_id": "5110c0c2-dcee-42a8-967e-e64759751c7a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33ebd29e-37e3-4ccf-a60a-57710ecbdd0b.pdf",
            "news_date": "2025-07-29 12:33:42",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results (Consolidated & Standalone) For The Quarter Ended June 30 2025",
            "news_body": "Financial Results (Consolidated & Standalone) for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33ebd29e-37e3-4ccf-a60a-57710ecbdd0b.pdf",
            "news_date": "2025-07-29 12:33:42"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Change In Statutory Auditors Of Material Subsidiary Of The Company In UK",
            "news_body": "Change in Statutory Auditors of Material Subsidiary of the Company in UK",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6ddb598-4b21-4b93-bdde-13def2b10933.pdf",
            "news_date": "2025-07-28 20:57:00"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Reminder To Shareholders About Transfer Of Equity Shares Relating To Unclaimed Dividend Of The Company To Investor Education And Protection Fund (IEPF)",
            "news_body": "Reminder to Shareholders regarding transfer of their Equity Shares relating to Unclaimed Dividend of the Company to IEPF",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae178255-f9dd-46ac-9502-c8c937f6bd59.pdf",
            "news_date": "2025-07-26 17:56:24"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Earnings Call to discuss unaudited financial results of the Company for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=624dcc7e-8f52-43bc-9625-0b4da9a560db.pdf",
            "news_date": "2025-07-23 19:17:21"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Regarding Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 inter alia to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday July 29 2025 to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter ended June 30 2025 amongst other matters.\r\n\r\nFurther as per provisions of the Companys Code of Conduct for Prohibition of Insider Trading trading window for Designated Persons of the Company is closed from July 1 2025 and shall open after 48 hrs post declaration of financial results by the Company.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2b4405f-9f11-4cd5-8b58-b62b40c6346d.pdf",
            "news_date": "2025-07-23 19:04:56"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Update regarding Companys intimated dated May 10 2025 in relation to movement in Senior Management Personnel.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=81af235b-fd0b-4fac-b1a3-c642c813de22.pdf",
            "news_date": "2025-07-22 18:39:00"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "BRSR for financial year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa19a3da-8bed-4d61-ba82-56e54a144c84.pdf",
            "news_date": "2025-07-11 15:35:14"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report for the financial year ending March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7591369b-b3bf-458a-9e6e-710f89f6bd4b.pdf",
            "news_date": "2025-07-11 15:32:17"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 34Th Annual General Meeting",
            "news_body": "Notice of 34th Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30223fcf-3e59-41a6-be26-77573a0c9c70.pdf",
            "news_date": "2025-07-11 15:23:15"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "No Objection Letter Received From Stock Exchanges.",
            "news_body": "No Objection received from BSE Limited and NSE Limited for Reclassification of Shasun Enterprises LLP and Ambemata Securities from \"Promoter Group\" to \"Public\" category",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52f7a8b0-eb73-4c33-b501-e1e948b39115.pdf",
            "news_date": "2025-07-10 17:50:25"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding Communication To Shareholders On TDS For Final Dividend For FY 2024-25",
            "news_body": "Intimation regarding communication to Shareholders on TDS for Final Dividend for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78637ecc-fdc1-4e72-bb8e-4e0bdda5d21e.pdf",
            "news_date": "2025-07-10 12:24:28"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding Communication To Shareholders On TDS For Final Dividend For FY 2024-25",
            "news_body": "Intimation regarding Communication to shareholders on TDS for Final Dividend for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a1e7be5-8bd4-447e-b218-82d0337ed0e1.pdf",
            "news_date": "2025-07-10 12:13:25"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation To Members About Record Date For The Purpose Of Final Dividend For FY25.",
            "news_body": "Intimation to members about Annual General Meeting of the Company and Record date for the purpose of Final Dividend for FY25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e02450c-d223-42fd-8d57-23b056dc8147.pdf",
            "news_date": "2025-07-09 13:47:00"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of trading window from July 1 2025 until 48 hours after declaration of financial results for quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7853cd61-ec25-4326-bc01-c8ab7127c263.pdf",
            "news_date": "2025-06-27 17:27:29"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Pursuant To Regulation 31A",
            "news_body": "Approval Letter dated June 27 2025 from BSE Limited and National Stock Exchange of India Limited for reclassification of Shasun Leasing and Finance Private Limited from Promoter Group to Public Category",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=afb6c14b-f1c8-4cde-a79a-e1e027fd3b77.pdf",
            "news_date": "2025-06-27 17:11:01"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Restructuring",
            "caption": "Announcement under Regulation 30 (LODR)-Restructuring",
            "news_body": "Divestment of a dormant step-down wholly owned subsidiary of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88eb5a42-f844-4ff2-82e5-197f79b5fb64.pdf",
            "news_date": "2025-06-16 19:23:21"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Intimation regarding superannuation of a Senior Management Personnel of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf537e4f-a3a6-46ba-9177-4f716618a4a8.pdf",
            "news_date": "2025-05-30 18:31:15"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Transcript of Earnings Call pertaining to Audited Financial Results of the Company for the quarter and financial year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16b39100-202b-45a3-89a5-d7161626f0d6.pdf",
            "news_date": "2025-05-27 17:33:13"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial Compliance Report for the year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d81b6b8-89f9-4660-88ad-98979f1d0b67.pdf",
            "news_date": "2025-05-27 12:12:29"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Pursuant To Regulation 31A Of The Sebl (Listing Obligations And Disclosure Requirements) Regulations 2015  Regarding Promoter Reclassification",
            "news_body": "Application for promoter reclassification",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34623e1a-0d84-44c9-8634-1d55ab3edcc5.pdf",
            "news_date": "2025-05-26 18:15:52"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement- Audited Financial Results for the Quarter and Financial Year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=265ae068-5c69-4fdc-b400-de4a4ff67428.pdf",
            "news_date": "2025-05-23 17:31:30"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Call pertaining to the Audited Financial Results for the quarter and financial year ended March 31 2025",
            "news_id": "98b483eb-5a97-480e-a461-7d2bd3b3101f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b72086bc-8a4e-436c-b5e3-f4f980a236d5.pdf",
            "news_date": "2025-05-22 19:12:14",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Call pertaining to the Audited Financial Results for the quarter and financial year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b72086bc-8a4e-436c-b5e3-f4f980a236d5.pdf",
            "news_date": "2025-05-22 19:12:14"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On May 22 2025",
            "news_body": "Outcome of Board Meeting held on May 22 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b741ebc4-c6c1-473f-8a73-049c1a0dc1b6.pdf",
            "news_date": "2025-05-22 13:45:42"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On Promoters Reclassification Request",
            "news_body": "Update on Promoters Reclassification Request",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73e0c1b0-d52e-45bb-9428-89150346cf41.pdf",
            "news_date": "2025-05-22 13:42:32"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Secretarial Auditor",
            "news_body": "Appointment of Secretarial Auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2e400b8-e2c8-44f0-b835-d0cdfcabbfab.pdf",
            "news_date": "2025-05-22 13:40:32"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Outcome",
            "descriptor": "Dividend/AGM",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Recommendation of final dividend of Rs. 4/- per equity share of Rs. 10 each (at the rate of 40%) for FY25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab511f81-7121-4d06-bc4b-9de913f3367f.pdf",
            "news_date": "2025-05-22 13:39:11"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Strides Delivers Strong FY25 Results Exceeding Outlook Across All Metrics",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ff85ea1-cf0c-4816-90bf-e6848599f92a.pdf",
            "news_date": "2025-05-22 13:37:04"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Of The Company Held On May 22 2025",
            "news_body": "Outcome of Board Meeting of the Company held on May 22 2025",
            "news_id": "bfe200db-0c2e-4a67-af50-dd7f2b4fc68a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b30c80ec-3405-467c-903a-716f508a8306.pdf",
            "news_date": "2025-05-22 13:33:53",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of Board Meeting Of The Company Held On May 22 2025",
            "news_body": "Outcome of Board Meeting of the Company held on May 22 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b30c80ec-3405-467c-903a-716f508a8306.pdf",
            "news_date": "2025-05-22 13:33:53"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Scheme of Arrangement",
            "caption": "Announcement under Regulation 30 (LODR)-Scheme of Arrangement",
            "news_body": "Demerger of Identified Business of Arco Lab Private Limited a wholly owned subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b0ef3aa-b62d-48f6-92a6-09f1f0ed3cd4.pdf",
            "news_date": "2025-05-15 21:21:56"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 31A Of SEBI Listing Regulations",
            "news_body": "Intimation under Regulation 31A of SEBI Listing Regulations",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=930362b3-caff-4a6b-9e43-3d1afae543cb.pdf",
            "news_date": "2025-05-15 21:17:54"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Earnings Call to discuss the audited financial results of the Company for the quarter and financial year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaede006-d7da-4120-99d8-bbcdabcfa8fc.pdf",
            "news_date": "2025-05-15 21:11:51"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation On Board Meeting",
            "news_body": "Strides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 inter alia to consider and approve Pursuant to Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of Board of Directors of the Company is scheduled to be held on Thursday May 22 2025 inter alia: \r\n\r\n1) To consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and financial year ended March 31 2025; and \r\n\r\n2) To consider and recommend final dividend if any on the equity shares of the Company for the financial year ended March 31 2025. \r\n\r\nFurther as per the provisions of the Companys Code of Conduct for Prohibition of Insider Trading trading window for designated persons of the Company has been closed from April 1 2025 and shall open after 48 hrs post declaration of financial results of the Company.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a0ef7c1-73ca-40bc-ba38-e52ebcb0e1bf.pdf",
            "news_date": "2025-05-15 21:07:13"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Movement in Senior Management Personnel of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11150bc9-df24-4564-ab21-0945318885a2.pdf",
            "news_date": "2025-05-10 12:28:25"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Strides strengthens Anti-Inflammatory Portfolio with USFDA approval for Celecoxib Capsules 100 mg 200 mg and 400 mg",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=514c6e01-fbc1-4b67-a6ad-dfaf15127cec.pdf",
            "news_date": "2025-04-30 15:04:39"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Strides Acquires Identified Andas From Nostrum Laboratories Inc. USA",
            "news_body": "Strides acquires identified ANDAs from Nostrum Laboratories Inc. USA",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17904954-1a36-4a7e-b7bd-612c180b8c17.pdf",
            "news_date": "2025-04-29 18:31:30"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Intimation about incorporation of Step-down Wholly Owned Subsidiary in India.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dabc484f-daba-4074-9b2e-3a6e99379b4c.pdf",
            "news_date": "2025-04-11 12:16:56"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation For Change In Details Of Key Managerial Personnel For Determining Materiality Of Events Or Information And Making Disclosure To Stock Exchange Under Regulation 30 Of SEBI Listing Regulations",
            "news_body": "Intimation for change in details of Key Managerial Personnel for determining materiality of events or information and making disclosure to Stock Exchanges under Regulation 30 of SEBI Listing Regulations effective April 5 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ff3cf75-b385-4c6a-9d94-278307fccaf9.pdf",
            "news_date": "2025-04-03 12:08:43"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On Redemption Of Secured Unlisted Redeemable Non-Convertible Debentures",
            "news_body": "Redemption of balance outstanding NCDs of Rs. 24.20 Crores.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b405f33-ef5b-43a7-beb1-61cf77dcd6aa.pdf",
            "news_date": "2025-04-01 18:22:20"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "Results and Scrutinizers report in respect of Postal ballot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bdb6c621-9d9f-4680-b3f6-d10714fbdbe0.pdf",
            "news_date": "2025-03-21 15:59:49"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Outcome",
            "descriptor": "Postal Ballot",
            "caption": " Shareholder Meeting / Postal Ballot-Scrutinizer\"s Report",
            "news_body": "Results along with Scrutinizers report for Postal Ballot process.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec5284a9-1e42-4e9f-9805-da2ef9512a07.pdf",
            "news_date": "2025-03-21 15:52:06"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Update regarding intimation of March 14 2025 relating to Amexel",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3bcb04d-78c8-45af-aab1-05e4a2865bd3.pdf",
            "news_date": "2025-03-19 17:25:21"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Proposed De-Merger Of Identified Business Of Arco Lab Private Limited (Arco Lab) A Wholly Owned Subsidiary Of The Company",
            "news_body": "Proposed de-merger of Identified Business of Arco Lab Private Limited a wholly owned subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b063046-75d6-4dda-bf36-a92388311714.pdf",
            "news_date": "2025-03-19 11:49:10"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Dissolution",
            "news_body": "Dissolution of a non-operating step-down wholly owned subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1db274b2-d2bb-48fc-baf9-f8b8ee1e89b3.pdf",
            "news_date": "2025-03-18 17:12:41"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Acquisition of 100% stake in Amexel Pte. Limited Singapore by Strides Pharma Global Pte. Limited step-down wholly-owned subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc2399c2-0948-4487-b498-1b52658a93b7.pdf",
            "news_date": "2025-03-14 18:07:34"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=386D1AA3_3688_4794_A530_A7E83D5FB5D6_104013.pdf",
            "news_date": "2025-02-19 10:40:30"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation about newspaper advertisement regarding dispatch of Postal Ballot Notice dated January 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f07540fd-715c-444f-9e6b-f0b1bae62c5d.pdf",
            "news_date": "2025-02-18 18:43:41"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Intimation",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
            "news_body": "Intimation on launch of Postal Ballot",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66dc48b7-214b-451f-8b8d-60aa22965b52.pdf",
            "news_date": "2025-02-17 17:00:46"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Transcript of Earnings Call pertaining to Un-Audited Financial Results of the Company for the quarter and nine months ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb0f8605-df29-4b18-89a6-1981d2e97582.pdf",
            "news_date": "2025-02-04 15:19:14"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of unaudited financial results for the quarter and nine months ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c2e9a6b-2d6c-4d43-adfc-943a718b802f.pdf",
            "news_date": "2025-01-31 17:24:43"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call pertaining to the Un-Audited Financial Results for the quarter and nine months ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0da04685-ff56-4e3b-b16e-1e0dfd079459.pdf",
            "news_date": "2025-01-30 18:26:16"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated Filing (Financials) for the quarter and nine months ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fccbe9af-30f5-4f8d-9922-10d2736b5c42.pdf",
            "news_date": "2025-01-30 16:38:38"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Registered Office Address",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Registered Office Address",
            "news_body": "Change in Registered office of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=676f29aa-4a84-4ddf-9950-f1e222639602.pdf",
            "news_date": "2025-01-30 13:31:26"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Appointment of Ms. Mukta Arora (DIN: 07225715) as Independent Director of the Company effective February 1 2025.\r\n\r\nChange in designation of Mr. Arun Kumar (DIN: 00084845) from Executive Chairperson to Non-Executive Chairperson of the Company effective April 5 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7b22d26a-de41-487a-a065-b707ed6f72f8.pdf",
            "news_date": "2025-01-30 13:30:05"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Strides Reports A Strong Q3FY25 Performance \r\nUpgrade Outlook to Top End of the Range Across Parameters",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=392b69e8-ef89-4d5b-8b83-4993e98cc39c.pdf",
            "news_date": "2025-01-30 13:27:16"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Outcome of Board Meeting - Un-audited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d7ece79-c6ea-41f3-9e05-b1a18e9ba3af.pdf",
            "news_date": "2025-01-30 13:24:36"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2024.",
            "news_id": "aa9ebb03-2d66-4975-9c93-f6515c7bde63",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c7fb38e-4d7b-4cf0-ba27-66648bac5e65.pdf",
            "news_date": "2025-01-30 13:21:51",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 16996,
            "bse_code": 532531,
            "isin": "INE939A01011",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c7fb38e-4d7b-4cf0-ba27-66648bac5e65.pdf",
            "news_date": "2025-01-30 13:21:51"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call pertaining to the Un-Audited Financial Results for the quarter and half-year ended September 30, 2024",
            "news_id": "6900a9ef-ce7c-4101-83c6-2b0e526441a1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=022c4317-c8c1-4f4a-a328-989f03fbc9fd.pdf",
            "news_date": "2024-10-24 19:18:58",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For Quarter And Half-Year Ended September 30, 2024",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) for quarter and half year ended September 30, 2024.",
            "news_id": "9dbcffbf-a621-40b1-88a5-ec2f0e5ffd8c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=342ea0a4-93f8-4caf-a592-b6e368b9f9de.pdf",
            "news_date": "2024-10-24 13:19:07",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For Quarter Ended June 30, 2024",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) for quarter ended June 30, 2024.",
            "news_id": "f51b55b4-160a-4187-bd9f-1c74a442a5ed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e79339fc-b780-4534-8aea-c180814ad730.pdf",
            "news_date": "2024-07-29 14:05:11",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - May 22, 2024",
            "news_body": "Outcome of Board Meeting - May 22, 2024",
            "news_id": "0203fc79-9407-4b06-b309-34c1b551c269",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=416d7b90-0799-4297-bf31-4e2d5c685010.pdf",
            "news_date": "2024-05-22 13:43:47",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "We would like to inform you that Management of Strides will be meeting investors/ analysts during the week of February 5, 2024.The investor deck which will be considered during these meetings is enclosed for your reference.",
            "news_id": "0bc289e7-8f00-42c2-ba32-2c5925d8b773",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe3ada58-ceee-4d6f-a372-390e314b16a7.pdf",
            "news_date": "2024-02-02 21:16:49",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Outcome of Board Meeting - Un-audited Financial Results (Standalone & Consolidated) for quarter and nine months ended December 31, 2023",
            "news_id": "291db42e-25ef-434c-b511-559fb6734869",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6d1d1ed-c4de-4160-af27-6cecd0887f76.pdf",
            "news_date": "2024-01-30 13:16:55",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Earnings Call - Audio recording",
            "news_id": "97dcd60b-8509-499c-b202-4ce408665c6a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d201d823-a062-4706-a9fb-a53efd23721b.pdf",
            "news_date": "2023-10-30 17:40:14",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For Quarter And Half Year Ended September 30, 2023",
            "news_body": "Outcome of Board Meeting - Un-audited Financial Results (Standalone & Consolidated) for quarter and half year ended September 30, 2023.",
            "news_id": "189b9e2a-2591-4886-b216-856817de819a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b3fbfed-82b7-41b5-9b2b-5474ffac6665.pdf",
            "news_date": "2023-10-30 12:16:27",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Investors call held today, September 25, 2023",
            "news_id": "dadc5f55-5296-4d47-9462-23d0e7b884c1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c7fb29e-ebef-499a-a2f8-0ce949df018b.pdf",
            "news_date": "2023-09-25 19:00:09",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call pertaining to the un-audited Financial Results for the quarter ended June 30, 2023.",
            "news_id": "29d1006c-4578-4351-9f8e-e9040b291627",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28a81972-fd9b-4bf4-8938-b05452aceab2.pdf",
            "news_date": "2023-08-02 19:02:52",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Un-Audited Financial Results (Standalone & Consolidated) For Quarter Ended June 30, 2023",
            "news_body": "Outcome of Board Meeting - Un-audited Financial Results (Standalone & Consolidated) for quarter ended June 30, 2023.",
            "news_id": "e5094d80-02b6-40ac-9366-c8c8113e289e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc66b2dc-6802-4d05-b0fb-96b8a37317d4.pdf",
            "news_date": "2023-08-02 11:51:45",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call transcript pertaining to Audited Financial Results for the quarter and year ended March 31, 2023.",
            "news_id": "51cc99f6-d051-4cb3-8c29-5967ff8236fb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6d49081-0415-4964-8893-1c31ae04c654.pdf",
            "news_date": "2023-06-01 10:48:49",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call pertaining to the Financial Results for the quarter and year ended March 31, 2023.",
            "news_id": "e5363367-adb5-4fd0-8d65-86860ea16487",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12279360-506b-40b4-8142-126ed21ccc85.pdf",
            "news_date": "2023-05-25 18:27:39",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Audited Financial Results (Standalone & Consolidated) For Quarter And Year Ended March 31, 2023",
            "news_body": "Outcome of Board Meeting - Audited Financial Results (Standalone & Consolidated) for quarter and year ended March 31, 2023",
            "news_id": "72c1849a-3f13-4080-9876-2f0a0f8affd2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=428e5cc4-15a5-43f5-9ea6-20284f19c156.pdf",
            "news_date": "2023-05-25 14:20:44",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call pertaining to the Financial Results for the quarter and nine months ended December 31, 2022",
            "news_id": "81b1b598-26bd-4308-9865-130bde0cb4b0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25d627fd-b81f-4d10-83e4-1de5d200c5be.pdf",
            "news_date": "2023-01-25 10:13:25",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31, 2022",
            "news_id": "ca8b402f-3387-4693-9f1f-ac87e6d76bac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3efab5e7-43c3-4425-9e95-f64cad905a0f.pdf",
            "news_date": "2023-01-24 14:41:10",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "With reference to above, please find enclosed the disclosure of Related Party Transactions, on consolidated basis, for the half year ended September 30, 2022.This is for your information and records.",
            "news_id": "1bd7ee5a-01f9-418a-a6f1-cde711bfb937",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae0a8a35-b0b9-4eb4-83f8-e150b49d3776.pdf",
            "news_date": "2022-11-28 20:51:17",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call pertaining to the Financial Results for the  quarter and half year ended September 30, 2022",
            "news_id": "b8bb4fdd-e5a4-4909-98bc-caea46756a3b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3daf6f1-fda9-4eff-a738-ed95643189d6.pdf",
            "news_date": "2022-11-16 16:47:37",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30, 2022",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2022",
            "news_id": "91b288aa-1593-4bf6-bce9-31d2a95d02f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fcbc544-bc51-4447-81ac-0a195f0a4c40.pdf",
            "news_date": "2022-11-14 15:17:59",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2022",
            "news_body": "Outcome of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2022",
            "news_id": "76ce84f5-e3b0-43f2-b036-332df6b9296e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8592a91-fc18-4b51-ab5f-fc1561c455cf.pdf",
            "news_date": "2022-07-29 13:11:31",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "With reference to above, please find enclosed the disclosure of Related Party Transactions, on consolidated basis, for the half year ended March 31, 2022 in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021. This is for your information and records.",
            "news_id": "be8b8fbf-3878-48c5-bd20-a92d795ce393",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86a69b94-4cb9-4825-8282-36d0015712b1.pdf",
            "news_date": "2022-06-08 19:07:43",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings call pertaining to the  Financial Results for the  Quarter and Financial Year Ended March 31, 2022.",
            "news_id": "c387f3d7-d698-4cfd-b683-b293c92fc23d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=397504ad-5046-4e38-9300-e54d350223ef.pdf",
            "news_date": "2022-05-25 14:34:12",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Audited Financial Results (Standalone & Consolidated) For The Quarter And Year Ended March 31, 2022",
            "news_body": "Outcome of Board Meeting - Audited Financial Results (Standalone & Consolidated) for the quarter and year ended March 31, 2022",
            "news_id": "e72d7773-f78f-494b-8dff-fbcc7a358ef2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f14edf4f-fdb8-4c9e-a26d-7fe192e8fad7.pdf",
            "news_date": "2022-05-24 21:31:53",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31, 2021",
            "news_body": "We are pleased to enclose the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter and nine months ended December 31, 2021, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard.<BR> <BR> The board meeting commenced at 11:30 hrs and concluded at 13:10 hrs.<BR> <BR> This is for your information and record.",
            "news_id": "bd64542e-3b7d-45d3-aa82-fc52281fa5d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a5b176c-7ce3-410b-b854-4bb710e827a8.pdf",
            "news_date": "2022-02-10 13:24:52",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "We are pleased to enclose the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter and half year ended September 30, 2021, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard.<BR> <BR> The board meeting commenced at 11:00 hrs and concluded at 13:30 hrs.<BR>  <BR> This is for your information and record.",
            "news_id": "293f80ed-8756-4802-8b1a-bd430406da9c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=653f56b3-9041-4a19-90b3-9f55c51b4251.pdf",
            "news_date": "2021-11-10 13:45:44",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2021",
            "news_body": "We are pleased to enclose the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter ended June 30, 2021, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard.<BR> <BR> The board meeting commenced at 10:15 hrs and concluded at 12:20 hrs.<BR> <BR> This is for your information and record.",
            "news_id": "6c718b94-55ce-42d6-8ba7-fb49ede4b017",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ba27bd4-de70-40d2-9ba1-294b8677ffd2.pdf",
            "news_date": "2021-08-06 12:47:26",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "With reference to above, please find enclosed the disclosure of Related Party Transactions, on consolidated basis, for the year ended March 31, 2021 drawn in accordance with applicable accounting standards.<BR>  <BR> This is for your information and records.",
            "news_id": "ee368fac-59ac-4309-bc2a-ffdcceda0fdc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5dfa4437-e5a2-41c9-9b32-1f36f6b7181d.pdf",
            "news_date": "2021-06-25 11:34:07",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "STAR",
            "disp": "Strides Pharma Science",
            "bse_code": 532531,
            "isin": "INE939A01011",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Audited Financial Results (Standalone & Consolidated) For The Quarter And Year Ended March 31, 2021",
            "news_body": "The Board of Directors at their meeting held today i.e., on May 27, 2021, has inter-alia, approved the Audited Financial Statements (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2021.  <BR> <BR> In this regard, please find enclosed the following:<BR> <BR> 1. A copy of the Audited Financial Statements (Standalone and Consolidated) for the quarter and year ended March 31, 2021 along with Auditors' Report for the said period;<BR> <BR> 2. Declaration on Unmodified Opinion in the Auditors' Report for Financial Year ended March 31, 2021; and<BR> <BR> 3. Press Release tilted 'Strides reports strong FY21 performance with 29% revenue and 67% EBITDA growth'.<BR> <BR> The Board Meeting commenced at 11:45 hrs and concluded at 13:15 hrs.<BR> <BR> This is for your information and record.",
            "news_id": "c1c57d3c-d44c-42e0-aef8-4e5cd622a757",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=705a7878-b9a6-421d-884a-47dfc3af9eb7.pdf",
            "news_date": "2021-05-27 13:33:32",
            "seo": "strides-pharma-science-ltd",
            "ltp": 875.6,
            "ch": -6.899999999999977,
            "pch": -0.7818696883852665,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 7374,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}